The mission of the Sidney Kimmel Cancer Center X-Ray Crystallography and Macromolecular Characterization Shared Resource (XSR) is to facilitate the design, acquisition, and interpretation of quantitative data relevant to the structure and function of cancer-related macromolecules; decipher the impact of mutations on protein folding and stability; and promote the understanding of macromolecular interactions at atomic detail. The XSR provides a single portal for SKCC members who require crystallization, X-ray data collection, structure determination, and functional dissection of macromolecular interactions. Founded in 2009, the XSR is the only facility of its kind in Philadelphia and is uniquely positioned to fill the needs of cancer biologists in macromolecular structure analysis and characterization by providing a unique array of specialized instruments that build upon expertise in biophysics, structural, and chemical biology. When former XSR Director Dr. John Pascal relocated to the University of Montreal in 2015, Gino Cingolani, PhD, took over as Director of the XSR. Co-Director Michael Root, PhD, continues to oversee the instrumentation dedicated to macromolecular characterization. Anshul Bhardwaj, PhD, the XSR facility manager, oversees the day-to-day operations of the XSR and supports the research of SKCC members through facility services and scientific collaboration. Current XSR goals are as follows: 1) Serve the needs of SKCC research programs in crystallization, X-ray data collection, structure determination, and biophysical characterization of macromolecules; 2) Assist with the design, acquisition, and interpretation of quantitative data relevant to the structure and function of cancer- related macromolecules; 3) Facilitate studies on how mutations impact folding, stability, and interactions of proteins important in oncogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA056036-21
Application #
9956994
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
21
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Hussain, Maha; Daignault-Newton, Stephanie; Twardowski, Przemyslaw W et al. (2018) Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. J Clin Oncol 36:991-999
Shafi, Ayesha A; Schiewer, Matthew J; de Leeuw, Renée et al. (2018) Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol 1:325-337
Meyer, Sara E; Muench, David E; Rogers, Andrew M et al. (2018) miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. J Exp Med 215:2115-2136
Mazina, Olga M; Mazin, Alexander V (2018) Reconstituting the 4-Strand DNA Strand Exchange. Methods Enzymol 600:285-305
Magee, Michael S; Abraham, Tara S; Baybutt, Trevor R et al. (2018) Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases. Cancer Immunol Res 6:509-516
Chervoneva, Inna; Freydin, Boris; Hyslop, Terry et al. (2018) Modeling qRT-PCR dynamics with application to cancer biomarker quantification. Stat Methods Med Res 27:2581-2595
Capparelli, Claudia; Purwin, Timothy J; Heilman, Shea A et al. (2018) ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma. Cancer Res 78:5680-5693
Nevler, Avinoam; Muller, Alexander J; Cozzitorto, Joseph A et al. (2018) A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2. J Am Coll Surg 226:596-603
Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38:
Waldman, Scott A; Camilleri, Michael (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:1543-1552

Showing the most recent 10 out of 807 publications